Janney Montgomery Scott LLC Halozyme Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 36,020 shares of HALO stock, worth $2.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

36,020

Previous 26,025 38.41%

Holding current value

$2.11 Million

Previous $1.36 Million 51.28%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$51.3 - $64.42 $512,743 - $643,877	9,995 Added 38.41%	36,020 $2.06 Million
Q2 2024 Jul 25, 2024	BUY	$37.81 - $52.4 $361,879 - $501,520	9,571 Added 58.17%	26,025 $1.36 Million
Q1 2024 May 01, 2024	BUY	$33.68 - $41.95 $123,470 - $153,788	3,666 Added 28.67%	16,454 $669,000
Q4 2023 Feb 07, 2024	BUY	$33.32 - $42.1 $426,096 - $538,374	12,788 New	12,788 $473,000
Q4 2022 Feb 01, 2023	BUY	$40.06 - $59.44 $332,097 - $492,757	8,290 New	8,290 $472,000
Q4 2021 Jan 27, 2022	SELL	$31.82 - $40.75 $177,714 - $227,588	-5,585 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$38.47 - $46.42 $284,870 - $343,740	-7,405 Reduced 57.01%	5,585 $227,000
Q2 2021 Jul 26, 2021	SELL	$38.84 - $51.31 $278,599 - $368,046	-7,173 Reduced 35.58%	12,990 $590,000
Q1 2021 Apr 27, 2021	BUY	$39.51 - $51.45 $231,765 - $301,805	5,866 Added 41.03%	20,163 $841,000
Q4 2020 Jan 25, 2021	BUY	$25.81 - $43.62 $369,005 - $623,635	14,297 New	14,297 $611,000
Q4 2019 Jan 21, 2020	SELL	$14.93 - $19.53 $674,880 - $882,814	-45,203 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$15.2 - $17.69 $274,952 - $319,994	-18,089 Reduced 28.58%	45,203 $701,000
Q2 2019 Jul 29, 2019	SELL	$14.75 - $17.26 $53,557 - $62,671	-3,631 Reduced 5.43%	63,292 $1.09 Million
Q1 2019 Apr 30, 2019	SELL	$13.94 - $17.58 $20,547 - $25,912	-1,474 Reduced 2.16%	66,923 $1.08 Million
Q4 2018 Feb 01, 2019	SELL	$13.33 - $18.66 $60,678 - $84,940	-4,552 Reduced 6.24%	68,397 $1 Million
Q3 2018 Nov 05, 2018	SELL	$16.68 - $18.41 $17,313 - $19,109	-1,038 Reduced 1.4%	72,949 $1.33 Million
Q2 2018 Jul 24, 2018	SELL	$16.87 - $20.3 $14,002 - $16,849	-830 Reduced 1.11%	73,987 $1.25 Million
Q1 2018 Apr 19, 2018	SELL	$17.06 - $21.2 $36,150 - $44,922	-2,119 Reduced 2.75%	74,817 $1.47 Million
Q4 2017 Feb 14, 2018	SELL	$16.75 - $20.8 $124,569 - $154,689	-7,437 Reduced 8.81%	76,936 $1.56 Million
Q3 2017 Nov 15, 2017	BUY	$11.76 - $17.4 $992,226 - $1.47 Million	84,373	84,373 $1.47 Million

Others Institutions Holding HALO

# of Institutions

531

Shares Held

122M

Call Options Held

199K

Put Options Held

77.1K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.16B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Halozyme Therapeutics, Inc. Transaction History